Nicoline Dorothea Daugaard , Rikke Tholstrup , Jakob Rask Tornby , Sofie Marchsteiner Bendixen , Frederik Tibert Larsen , Daniela De Zio , Mike Bogetofte Barnkob , Kim Ravnskjaer , Jonathan R. Brewer
{"title":"人类黑色素瘤皮肤癌模型的特征描述:向基于模型的黑色素瘤研究迈出一步。","authors":"Nicoline Dorothea Daugaard , Rikke Tholstrup , Jakob Rask Tornby , Sofie Marchsteiner Bendixen , Frederik Tibert Larsen , Daniela De Zio , Mike Bogetofte Barnkob , Kim Ravnskjaer , Jonathan R. Brewer","doi":"10.1016/j.actbio.2024.11.018","DOIUrl":null,"url":null,"abstract":"<div><div>Advancing 3D in vitro human tissue models is crucial for biomedical research and drug development to address the ethical and biological limitations of animal testing. Recently, 3D skin models have proven to be effective for studying serious skin conditions, such as melanoma. For these advanced models to be applicable in preclinical studies, thorough characterization is essential to understand their applicability and limitations.</div><div>In this study, we used bioimaging and RNA sequencing to assess the architecture and transcriptomic profiles of skin models, including models with melanoma. Our results indicated that these models closely mimicked skin morphology and gene expression patterns. The full-thickness (FT) model shows a superior resemblance to the human skin, particularly in basement membrane formation and cellular interactions.</div><div>The integrity of the skin-like properties and gene expression signatures of both skin and melanoma cells were preserved upon the integration of melanoma cells, establishing these models as robust platforms for cancer research. The responsiveness of the FT melanoma models to vemurafenib treatment was successfully monitored, demonstrating their validity as a reliable, reproducible, and humane tool for pharmacological testing and drug development. Furthermore, the transcriptomic data showed that skin models with cancer spheroids had upregulated genes linked to aggressive and resilient cancer behavior compared to spheroids alone. This emphasizes the importance of the microenvironment in cancer progression and suggests that 3D skin models can serve to uncover mechanisms and therapeutic targets that are not detectable in simpler systems.</div></div><div><h3>Statement of significance</h3><div>This study introduces advanced, ethically sound skin and melanoma models as alternatives to animal testing in drug discovery. By thoroughly characterizing these models using bioimaging and RNA sequencing, we demonstrate their close resemblance to human skin, particularly in full-thickness models. These models not only replicate the complex cellular interactions and gene expression patterns of human tissue but also maintain robustness after melanoma integration. Our findings highlight the potential of these models in revealing cancer mechanisms and therapeutic targets, offering a significant impact on melanoma research and preclinical testing.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"191 ","pages":"Pages 308-324"},"PeriodicalIF":9.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Characterization of human melanoma skin cancer models: A step towards model-based melanoma research\",\"authors\":\"Nicoline Dorothea Daugaard , Rikke Tholstrup , Jakob Rask Tornby , Sofie Marchsteiner Bendixen , Frederik Tibert Larsen , Daniela De Zio , Mike Bogetofte Barnkob , Kim Ravnskjaer , Jonathan R. Brewer\",\"doi\":\"10.1016/j.actbio.2024.11.018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Advancing 3D in vitro human tissue models is crucial for biomedical research and drug development to address the ethical and biological limitations of animal testing. Recently, 3D skin models have proven to be effective for studying serious skin conditions, such as melanoma. For these advanced models to be applicable in preclinical studies, thorough characterization is essential to understand their applicability and limitations.</div><div>In this study, we used bioimaging and RNA sequencing to assess the architecture and transcriptomic profiles of skin models, including models with melanoma. Our results indicated that these models closely mimicked skin morphology and gene expression patterns. The full-thickness (FT) model shows a superior resemblance to the human skin, particularly in basement membrane formation and cellular interactions.</div><div>The integrity of the skin-like properties and gene expression signatures of both skin and melanoma cells were preserved upon the integration of melanoma cells, establishing these models as robust platforms for cancer research. The responsiveness of the FT melanoma models to vemurafenib treatment was successfully monitored, demonstrating their validity as a reliable, reproducible, and humane tool for pharmacological testing and drug development. Furthermore, the transcriptomic data showed that skin models with cancer spheroids had upregulated genes linked to aggressive and resilient cancer behavior compared to spheroids alone. This emphasizes the importance of the microenvironment in cancer progression and suggests that 3D skin models can serve to uncover mechanisms and therapeutic targets that are not detectable in simpler systems.</div></div><div><h3>Statement of significance</h3><div>This study introduces advanced, ethically sound skin and melanoma models as alternatives to animal testing in drug discovery. By thoroughly characterizing these models using bioimaging and RNA sequencing, we demonstrate their close resemblance to human skin, particularly in full-thickness models. These models not only replicate the complex cellular interactions and gene expression patterns of human tissue but also maintain robustness after melanoma integration. Our findings highlight the potential of these models in revealing cancer mechanisms and therapeutic targets, offering a significant impact on melanoma research and preclinical testing.</div></div>\",\"PeriodicalId\":237,\"journal\":{\"name\":\"Acta Biomaterialia\",\"volume\":\"191 \",\"pages\":\"Pages 308-324\"},\"PeriodicalIF\":9.4000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Biomaterialia\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1742706124006731\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Biomaterialia","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1742706124006731","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
摘要
推进三维体外人体组织模型对于生物医学研究和药物开发至关重要,以解决动物试验在伦理和生物学方面的局限性。最近,三维皮肤模型已被证明可有效研究黑色素瘤等严重皮肤病。要想将这些先进的模型应用于临床前研究,就必须对其进行全面鉴定,以了解其适用性和局限性。在这项研究中,我们利用生物成像和 RNA 测序技术评估了皮肤模型(包括黑色素瘤模型)的结构和转录组特征。我们的结果表明,这些模型密切模拟了皮肤形态和基因表达模式。全厚(FT)模型与人类皮肤的相似度更高,尤其是在基底膜形成和细胞相互作用方面。在整合黑色素瘤细胞后,皮肤和黑色素瘤细胞的类肤特性和基因表达特征的完整性得以保留,从而使这些模型成为癌症研究的可靠平台。成功监测了 FT 黑色素瘤模型对维莫非尼治疗的反应性,证明了它们作为药理测试和药物开发的可靠、可重复和人性化工具的有效性。此外,转录组数据显示,与单独的癌症球形体相比,带有癌症球形体的皮肤模型与侵袭性和复原性癌症行为相关的基因上调。这强调了微环境在癌症进展中的重要性,并表明三维皮肤模型可用于发现在简单系统中无法检测到的机制和治疗靶点。意义说明:这项研究引入了先进的、符合伦理道德的皮肤和黑色素瘤模型,作为药物研发中动物试验的替代方法。通过使用生物成像和 RNA 测序对这些模型进行彻底的特征描述,我们证明了它们与人类皮肤非常相似,尤其是在全厚模型中。这些模型不仅复制了人体组织复杂的细胞相互作用和基因表达模式,而且在黑色素瘤整合后仍能保持稳健性。我们的研究结果凸显了这些模型在揭示癌症机制和治疗靶点方面的潜力,对黑色素瘤研究和临床前测试产生了重大影响。
Characterization of human melanoma skin cancer models: A step towards model-based melanoma research
Advancing 3D in vitro human tissue models is crucial for biomedical research and drug development to address the ethical and biological limitations of animal testing. Recently, 3D skin models have proven to be effective for studying serious skin conditions, such as melanoma. For these advanced models to be applicable in preclinical studies, thorough characterization is essential to understand their applicability and limitations.
In this study, we used bioimaging and RNA sequencing to assess the architecture and transcriptomic profiles of skin models, including models with melanoma. Our results indicated that these models closely mimicked skin morphology and gene expression patterns. The full-thickness (FT) model shows a superior resemblance to the human skin, particularly in basement membrane formation and cellular interactions.
The integrity of the skin-like properties and gene expression signatures of both skin and melanoma cells were preserved upon the integration of melanoma cells, establishing these models as robust platforms for cancer research. The responsiveness of the FT melanoma models to vemurafenib treatment was successfully monitored, demonstrating their validity as a reliable, reproducible, and humane tool for pharmacological testing and drug development. Furthermore, the transcriptomic data showed that skin models with cancer spheroids had upregulated genes linked to aggressive and resilient cancer behavior compared to spheroids alone. This emphasizes the importance of the microenvironment in cancer progression and suggests that 3D skin models can serve to uncover mechanisms and therapeutic targets that are not detectable in simpler systems.
Statement of significance
This study introduces advanced, ethically sound skin and melanoma models as alternatives to animal testing in drug discovery. By thoroughly characterizing these models using bioimaging and RNA sequencing, we demonstrate their close resemblance to human skin, particularly in full-thickness models. These models not only replicate the complex cellular interactions and gene expression patterns of human tissue but also maintain robustness after melanoma integration. Our findings highlight the potential of these models in revealing cancer mechanisms and therapeutic targets, offering a significant impact on melanoma research and preclinical testing.
期刊介绍:
Acta Biomaterialia is a monthly peer-reviewed scientific journal published by Elsevier. The journal was established in January 2005. The editor-in-chief is W.R. Wagner (University of Pittsburgh). The journal covers research in biomaterials science, including the interrelationship of biomaterial structure and function from macroscale to nanoscale. Topical coverage includes biomedical and biocompatible materials.